Antiviral Agents Bulletin - 1995 U.S. Patent Indexes
As published in the April 1996 issue of the Antiviral Agents Bulletin.
Indexes - U.S. Patents 1995
The Antiviral Agents Bulletin published 419 antiviral and virus-related abstracts/claims for U.S. patents issued during 1995. The following indexes to 1995 patents are presented below:
- Assignee Index
- Assignee Country Index
- Virus/Disease Index
- Antiviral Agent Index
- Vaccine Index
- Immune Modulator Index
- Diagnostics Index
- Recombinant DNA/RNA Index
These are followed by listings of:
- Nucleoside/Nucleotide Patents
- Blood Treatment Patents
- Disinfectant/Sterilization Patents
- Veterinary Use Patents
Index entries refer to the monthly issue of the Bulletin which presented the abstract and/or exemplary claim for these patents followed by the U.S. patent number. Within the "U.S. Patents" section of each issue of the Bulletin, patents are arranged in numerical order.
**************
Assignee Index
Patent assignees are indexed below. In a few cases, patents are also indexed to parent companies. Patents unassigned or assigned to individuals are not listed below.
Abbott Labs. - May, 5,403,826; Dec., 5,455,351; 5,457,111; 5,457,194; 5,461,067
Acic (Canada) Inc. - Mar., 5,387,677; May, 5,399,682
Agency of Industrial Science & Technology (Japan) - Sep., 5,436,330
Agracetus, Inc. - May, 5,405,779
Ajinomoto Co., Inc. - Apr., 5,399,554; 5,399,669; Nov., 5,449,840; 5,451,671; Jan. 96, 5,464,819; 5,466,793
Akzo Nobel N.V. - Feb., 5,378,467; Mar., 5,384,240; Aug., 5,424,398; Nov., 5,449,765; Jan. 96, 5,464,621; 5,470,734
Albert Einstein College of Medicine - Mar., 5,387,611
Alcide Corp. - Feb., 5,384,134
American Cyanamid Co. - June, 5,414,076; Aug., 5,428,167; Sep., 5,430,150; Dec., 5,461,029
American Home Products Corp. (see also American Cyanamid) - Feb., 5,380,734; Feb. 96; 5,475,012
Amoco Corp. - Feb. 96, 5,472,840
AMUR Research Corp. - Jan. 96, 5,464,740
Antivirals Inc. - Feb., 5,378,841
Arch Development Corp. - Feb. 96, 5,478,727
Arthur Webster Pty. Ltd. - Sep., 5,436,005
Astra AB - Oct., 5,441,976
Atlantic Pharmaceutical Products Ltd. - Dec., 5,458,889
Baxter International, Inc. - Jan. 96, 5,466,725
Bayer AG - Mar., 5,385,899; Aug., 5,424,426; Sep., 5,430,151; Dec., 5,457,108
Behringwerke AG - Feb., 5,382,509; Aug., 5,424,197
Bio-Mega/Boehringer Ingelheim - Feb., 5,380,727; Feb. 96, 5,476,841
BioChem Immunosystems, Inc. - Aug., 5,427,792
Biochem Pharma Inc. - Jan. 96, 5,466,806
Bioclonetics Inc. - Dec., 5,459,060
Biogen Inc. - May, 5,401,642; 5,401,658
Boehringer Ingelheim Animal Health, Inc. - Feb. 96, 5,476,778
Boehringer Ingelheim Intl. GmbH - Nov., 5,447,840; 5,449,756
Boehringer Mannheim GmbH - Apr., 5,397,794; Nov., 5,446,139; Dec., 5,459,033
Boron Biologicals, Inc. - Dec., 5,455,233
Boyce Thompson Inst. for Plant Res. - Feb. 96, 5,475,090
Bristol-Myers Squibb Co. - May, 5,399,775; June, 5,414,000; 5,414,096; Jan. 96, 5,466,450; 5,466,787
British Biotech Pharmaceuticals Ltd. - Dec., 5,463,024
Burroughs Wellcome Co. - Apr., 5,393,883; 5,399,580; May, 5,405,850; June, 5,409,810; Aug., 5,424,295
Calypte Inc. - Nov., 5,447,837
Cambridge Biotech Corp. - Oct., 5,443,829
Carbomedics, Inc. - Oct., 5,437,287
Carrington Laboratories, Inc. - Oct., 5,441,943
Celgene Corp. - Dec., 5,463,063
Cell Genesys, Inc. - June, 5,413,923
CellPro Inc. - Feb., 5,378,624
Cetus Oncology Corp. - Jan. 96, 5,464,936
Cetylite Industries, Inc. - May, 5,407,949; Aug., 5,424,323
Charm Sciences Inc. - Mar., 5,389,335
Chiba Flour Milling Co. Ltd. - Feb., 5,382,430
Chiron Corp. - Feb., 5,378,814; Mar., 5,389,528; Apr., 5,397,703; May, 5,407,795; Feb. 96, 5,474,914
Ciba-Geigy Corp. - Apr., 5,393,878; June, 5,409,927; Dec., 5,461,152; Jan. 96, 5,466,585
Cold Spring Harbor Labs. - Nov., 5,453,362
Columbia Univ. - July, 5,422,274; Feb. 96, 5,474,771
Connaught Labs. Ltd. - Oct., 5,439,809
Creative Biomolecules, Inc. - Feb. 96, 5,476,786
Cryopharm Corp. - July, 5,418,130
Cytocolor Inc. - May, 5,407,794
Dade International Inc. - Oct., 5,437,974
Dainippon Ink & Chemicals Inc. - Dec., 5,459,257
Dallas Biotherapeutics, Inc. - Sep., 5,431,909
Dana-Farber Cancer Inst. - Aug., 5,424,197; Sep., 5,432,076; Nov., 5,447,915
Development Center for Biotechnology - Dec., 5,462,863
Dow Chemical Co. - July, 5,424,063
Du Pont Merck Pharmaceutical Co. - Sep., 5,430,155; Jan. 96, 5,466,797
Duke Univ. - Oct., 5,443,964; Dec., 5,455,233; Jan. 96, 5,464,933
Eastman Kodak Co. - May, 5,403,707
Efamol Holding PLC - July, 5,422,115
Eli Lilly & Co. (use Lilly, Eli & Co.)
Emory Univ. - Sep., 5,432,273; Oct., 5,444,063
Enzon Labs, Inc. - Dec., 5,455,030
Ethicon, Inc. - Jan. 96, 5,464,869
Farmitalia Carlo Erba S.r.l. - Aug., 5,424,308
Fox Chase Cancer Center - Mar., 5,389,514
Fred Hutchinson Cancer Research Center - Jan. 96, 5,470,726; 5,470,730
Fujikura Kasei Co. Ltd. - May, 5,401,626
Gamble Institute of Medical Res. - Feb. 96, 5,474,773
Genelabs Technologies, Inc. - Sep., 5,436,318; Oct., 5,441,983; 5,443,965
Genentech, Inc. - July, 5,420,020; Dec., 5,460,811; Jan. 96, 5,470,560
General Hospital Corp. - July, 5,420,264
Genetic Systems Corp. - Oct., 5,439,792
Genetics Institute Inc. - Dec., 5,457,038
Georgia State Research Foundation, Inc. - Oct., 5,439,814
Gilead Sciences, Inc. - Apr., 5,399,676; Sep., 5,434,257
Glaxo Wellcome (see Burroughs Wellcome)
Gšdecke AG - Oct., 5,438,050
Harvard College - Nov., 5,447,915
Health Research Inc. - Nov., 5,453,364
Hickam, Dow B. Inc. - Feb., 5,378,451
Hind Health Care, Inc. - June, 5,411,738
Hoechst AG - Aug., 5,424,311; Dec., 5,457,091; 5,462,933
Hoffmann-La Roche Inc. - Feb., 5,382,657; Mar., 5,386,022; 5,389,512; May, 5,407,800; Sep., 5,430,041; Nov., 5,446,161; 5,447,839; 5,451,678
Houghten Pharmaceuticals Inc. - Oct., 5,441,936
IDT, Inc. - Feb. 96, 5,476,444
Immunex Corp. - Jan. 96, 5,464,938; 5,470,730
Immuno AG - Mar., 5,391,491; Oct., 5,445,953
Immuno Japan, Inc. - Aug., 5,427,909; 5,428,145
Immunotec Research Corp. Ltd. - Dec., 5,456,924
Institut National de la Recherche Agronomique - Feb., 5,378,823
Institut National de la Sante et de la Recherche Medical; Institut Pasteur - June, 5,411,857
Institut Pasteur - Apr., 5,393,744; June, 5,411,857; Jan. 96, 5,470,702
Institut Swisse de Recherches Experimentales sur le Cancer - Oct., 5,443,832
Institute of Organic Chemistry & Biochemistry of the Academy of Sciences of the Czech Republic - Mar., 5,386,030; Feb. 96, 5,476,938
International Laboratory Tech. Corp. - June, 5,417,968
Iowa State Univ. Res. Found., Inc. - July, 5,419,907
Isis Pharmaceuticals - Feb., 5,378,825; Mar., 5,386,023; Oct., 5,442,049; Dec., 5,457,189; Dec., 5,459,255
Jagotec AG - Aug., 5,422,123
Janssen Pharmaceutica N.V. - May, 5,407,961
Japan Tobacco Inc. - June, 5,416,204; Feb. 96, 5,476,780
Japanese Foundation for Cancer Research - Apr., 5,399,669
Johns Hopkins Univ. - May, 5,407,801
Johnson Matthey PLC - June, 5,413,788
Kaken Pharmaceutical Co. - Aug., 5,424,300
Kansas State Univ. Research Found. - July, 5,424,189
Korea Green Cross Corp. - Oct., 5,443,828
Korean Assn. of Creation Res. - Jan. 96, 5,468,487
La Jolla Pharmaceutial Co. - Apr., 5,391,785
Lafor Laboratories Ltd. - Jan. 96, 5,466,463
LIDAK Pharmaceuticals, Inc. - Feb. 96, 5,476,996
Life Technologies, Inc. - May, 5,405,776
Lilly, Eli & Co. - May, 5,401,838; July, 5,420,266; Aug., 5,424,416; 5,426,183; Sep., 5,430,026; 5,434,254; 5,434,265; Dec., 5,461,154; Feb. 96, 5,475,136
Lynx Therapeutics Inc. - Apr., 5,395,928
Magainin Pharmaceuticals Inc. - Aug., 5,424,290
Marion Merrell Dow Pharm., Inc. - Feb., 5,378,693; Mar., 5,385,911; July, 5,424,063
Massachusetts Health Res. Inst., Inc. - June, 5,412,077
Matsushita Electric Industrial Co., Ltd. - Sep., 5,429,819
Medical Research Council - Feb., 5,384,122
Medivir AB - June, 5,409,906; Oct., 5,440,040; 5,446,029; Feb. 96, 5,473,063
Merck & Co. - Mar., 5,387,512; June, 5,413,999; Sep., 5,436,131; Jan. 96, 5,463,067; Feb. 96, 5,475,109; 5,476,874
MicroBioMed Corp. - July, 5,420,136
Miles Inc. - July, 5,419,906
Ministry of Intl. Trade & Industry (Japan) - Sep., 5,436,330
Minnesota Mining & Mfg. Co. - Mar., 5,389,640; Oct., 5,444,065
Mitsubishi Kasei Corp. - Dec., 5,461,060
ML Laboratories - Oct., 5,439,892
Molecular Engineering Associates, Inc. - Aug., 5,427,782
Monsanto Co. - Feb. 96, 5,475,013
Morinaga Milk Industry Co., Ltd. - Jan. 96, 5,466,669
National Fed. of Agric. Coop. Assn. (Japan) - Feb. 96, 5,478,559
NeoRx Corp. - Apr., 5,391,723
Neu-Gene Development Group - Jan. 96, 5,470,974
New York Blood Center - Oct., 5,444,044
New York Univ. - Mar., 5,386,020; 5,387,519
Nippon Zeon Co., Ltd. - May, 5,403,582
Nisshin Oil Mills Ltd. - Feb., 5,380,832
North Carolina State Univ. - June, 5,413,927; Aug., 5,428,166
Northwestern Univ. - Feb. 96, 5,476,930
Oclassen Pharmaceuticals, Inc. - Sep., 5,432,165
Octamer, Inc. - Jan. 96, 5,464,871; Feb. 96, 5,473,074
Organetics Ltd. - Mar., 5,391,142
Ortho Diagnostic Systems Inc. - May, 5,401,628
Otsuka Pharmaceutical Co., Ltd. - Jan. 96, 5,464,833
Parhelion Corp. - Dec., 5,460,815
Pharmacia Genetic Engineering Inc. - Jan. 96, 5,470,720
PharmaMar, S.A. - Nov., 5,449,684
Previsan SA - Apr., 5,399,555
Princeton Univ. - July, 5,422,251; Sep., 5,436,146
Procter & Gamble Co. - Dec., 5,461,075
Pulmonary Data Service Instrumentation Inc. - Mar., 5,390,668
Purdue Research Foundation - Oct., 5,439,899
Quality Biological, Inc. - Feb. 96, 5,474,894
Research Corp. Technologies Inc. - Feb., 5,378,806; Aug., 5,426,180; Jan. 96, 5,470,718
Research Development Foundation - Jan. 96, 5,464,630
Rockefeller Univ. - Mar., 5,385,901
Rost, Inc. - Oct., 5,441,723
Rush Presbyterian St. Lukes Medical Center - Aug., 5,426,028
Rutgers Univ. - Oct., 5,443,969
Safe Sex Products Licensing Societe Anonyme - Oct., 5,439,685
Sanofi SA - July, 5,417,970
Schering Corp. - Feb., 5,378,694; 5,382,572; Oct., 5,441,734; Nov., 5,449,685; 5,449,782; Dec., 5,459,144; 5,459,146; 5,460,956
Scottish Crop Research Institute - Dec., 5,462,853
Scripps Research Inst. - Apr., 5,393,879; May, 5,401,627; Oct., 5,441,942
Searle & Co. - Apr., 5,391,746; June, 5,411,970; Sep., 5,436,341; Nov., 5,451,679; Jan. 96, 5,463,104; Feb. 96, 5,475,027
Secretech, Inc. - Aug., 5,427,782
Seikagaku Kogyo K.K. - Nov., 5,449,752
Shin-Etsu Chemical Co., Ltd. - Sep., 5,436,127
Shionogi & Co. - Feb. 96, 5,472,965
Sigma Chemical Co. - Feb., 5,380,825
SmithKline Beecham Corp. - July, 5,420,154; 5,422,274; Oct., 5,438,118; Dec., 5,462,872
Solvay Animal Health, Inc. - Oct., 5,443,982
Southern Research Inst. - Feb. 96, 5,478,928
SRI International - Aug., 5,424,315
Stanford Univ. - June, 5,415,874; 5,415,995
Steigerwald Arzneimittelwerk GmbH - May, 5,401,777
Steritech, Inc. - May, 5,399,719; Dec., 5,459,030
Sterling Winthrop Inc. - Nov., 5,449,691; Jan. 96, 5,464,848; 5,466,715
Stichting Rega VZW - Mar., 5,386,030
Sumika Fine Chemicals Co. Ltd. - Mar., 5,389,637; Apr., 5,391,733; Oct., 5,440,037
Surtech International Ltd. - Feb., 5,382,436
Synbiotics Corp. - Jan. 96, 5,470,711
Syntex (U.S.A.) Inc. (see also Hoffmann-La Roche Inc.) - Nov., 5,446,137; 5,449,664
Syntro Corp. - Feb., 5,382,425; Nov., 5,451,499
SyStemix, Inc. - June, 5,411,749
Teijin Ltd. - Oct., 5,445,960
Temple Univ. - May, 5,405,939
Terochem Labs., Ltd. - June, 5,410,033
Therion Biologics Corp. - July, 5,420,026
Thomas Jefferson Univ. - Feb., 5,378,605
Toa Nenryo Kogyo K.K. - Aug., 5,426,051
Toronto Research Chemicals Inc. - Jan. 96, 5,466,809
Triumf Inc. - July, 5,422,345
Tularik Inc. - Nov., 5,453,362
U.S. Dept. of Agriculture - May, 5,403,582; Nov., 5,449,610
U.S. Public Health Service (NIH; CDC) - Feb., 5,378,805; 5,380,830; Apr., 5,397,696; 5,399,346; July, 5,419,900; 5,420,030; 5,420,244; 5,422,344; Aug., 5,428,143; Sep., 5,430,135; Oct., 5,437,951; 5,439,899; 5,445,932; Nov., 5,449,608; Dec., 5,455,251; 5,459,056; 5,462,852; Jan. 96, 5,468,469; 5,470,726; Feb. 96, 5,474,935; 5,476,658; 5,478,746
UAB Research Foundation (use Univ. of Alabama at Birmingham)
United Biomedical Inc. - Apr., 5,395,751; Sep., 5,436,126; Dec., 5,459,238; Feb. 96, 5,476,765
Univ. of Alabama at Birmingham - Nov., 5,453,533; Jan. 96, 5,464,748
Univ. of Arizona - Oct., 5,445,960
Univ. of British Columbia - Apr., 5,399,583; May, 5,405,957
Univ. of California - June, 5,410,031; Aug., 5,426,028; Sep., 5,436,139; Dec., 5,462,750; Jan. 96, 5,464,823; 5,464,936
Univ. of Colorado - June, 5,413,914
Univ. of Delaware - Oct., 5,443,831
Univ. of Florida - Mar., 5,391,563; Dec., 5,455,277; Jan. 96, 5,466,702; Feb. 96, 5,476,781
Univ. of Georgia - Dec., 5,455,339
Univ. of Iowa - Mar., 5,385,839
Univ. of Kentucky - Feb., 5,380,523
Univ. of Melbourne - Apr., 5,395,759
Univ. of Miami - Aug., 5,427,781
Univ. of Michigan - Apr., 5,399,493
Univ. of Minnesota - May, 5,409,698; Aug., 5,427,791
Univ. of North Carolina - June, 5,413,923; 5,416,260; Dec., 5,455,233
Univ. of Puerto Rico - Jan. 96, 5,470,572
Univ. of Saskatchewan - Sep., 5,431,899
Univ. of Texas - June, 5,410,045; July, 5,417,978; Sep., 5,432,171; Oct., 5,439,570; Nov., 5,451,576; Feb. 96, 5,475,104
Univ. of Virginia - July, 5,422,097; Jan. 96, 5,470,570
University Patents, Inc. - Nov., 5,453,496
University Research Corp. - Feb. 96, 5,475,096
Upjohn Co. - Sep., 5,434,157
Vestar, Inc. - June, 5,411,947; Jan. 96, 5,463,092
Vical, Inc. - Dec., 5,459,127
Virginia Commonwealth Univ. - May, 5,407,684; Aug., 5,427,907
Virogenetics Corp. - Feb., 5,378,457
ViroTex Corp. - Feb., 5,380,754
Warner-Lambert Co. - Aug., 5,424,329; Sep., 5,434,188; Oct., 5,444,085; Jan. 96, 5,463,122
Washington Univ. - Apr., 5,397,701; July, 5,418,132
Whitehead Inst. for Biomedical Research - Nov., 5,449,614
Wisconsin Alumni Res. Foundation - Aug., 5,422,253; Dec., 5,462,734
Yale Univ. - Dec., 5,462,733
Yamasa Shoyu K.K. - Sep., 5,430,139; Oct., 5,446,031
Yeda Res. & Dev. Co., Ltd. - Jan. 96, 5,468,607; 5,468,608; 5,468,609
Yeshiva Univ. - Mar., 5,387,611
Assignee Country Index
Patents are indexed below according to where their assignees are located. Note, patents assigned to U.S. organizations (325 or 78%) are not specifically listed.
Australia - Sep., 5,436,005
Austria - Mar., 5,391,491; Oct., 5,445,953
Belgium - May, 5,407,961; Dec., 5,456,924
Canada - Feb., 5,380,727; Mar., 5,387,677; Apr., 5,399,583; May, 5,399,682; 5,405,957; Sep., 5,431,899; Oct., 5,439,809; Jan. 96, 5,466,809; Feb. 96, 5,476,841
Czechoslovakia - Dec., 5,456,924; Feb. 96, 5,476,938
France - Feb., 5,378,823; Apr., 5,393,744; June, 5,411,857; July, 5,417,970; Jan. 96, 5,470,702
Germany - Mar., 5,385,899; Apr., 5,397,794; May, 5,401,777; Aug., 5,422,123; 5,424,197; 5,424,311; 5,424,426; 5,427,792; Sep., 5,430,151; Oct., 5,438,050; Nov., 5,446,139; Dec., 5,457,091; 5,457,108; 5,459,033; 5,462,933; Jan. 96, 5,466,806; 5,468,607; 5,468,608; 5,468,609
Italy - Aug., 5,424,308
Japan - Mar., 5,387,519; 5,389,637; Apr., 5,391,733; 5,399,554; 5,399,669; May, 5,401,626; 5,403,582; June, 5,410,033; 5,416,204; Aug., 5,424,300; 5,426,051; 5,427,909; 5,428,145; Sep., 5,429,819; 5,430,139; 5,436,127; 5,436,330; Oct., 5,440,037; 5,445,960; 5,446,031; Nov., 5,449,840; 5,451,671; Dec., 5,459,257; 5,461,060; Jan. 96, 5,464,819; 5,464,833; 5,466,669; 5,466,793; 5,472,965; Feb. 96, 5,476,780; 5,478,559
Korea - Oct., 5,443,828; Jan. 96, 5,468,487
Luxemburg - Apr., 5,399,555
Netherlands - Mar., 5,384,240; Aug., 5,424,398; Nov., 5,449,765; Jan. 96, 5,464,621; 5,470,734
Spain - Nov., 5,449,684
Sweden - June, 5,409,906; Oct., 5,440,040; 5,441,976; 5,446,029; Jan. 96, 5,470,720; Feb. 96, 5,473,063
Switzerland - Oct., 5,443,832
Taiwan - Dec., 5,462,863
U.K. - Feb., 5,382,436; 5,384,122; June, 5,413,788; July, 5,422,115; Dec., 5,462,853; 5,463,024
U.S.A. - All others, 325 total patents. Specific patents not listed.
Virus/Disease Index
Viruses and/or diseases are indexed below. Viral diseases are generally indexed by virus rather than disease name.
adeno-associated virus - Sep., 5,436,146; Feb. 96, 5,474,935
avipoxvirus vectors - Mar., 5,387,519
baculoviruses - Feb. 96, 5,475,090
bovine herpesvirus 1 - Dec., 5,462,734
bovine immunodeficiency-like virus - Feb., 5,380,830
canine coronavirus vaccine - Jan. 96, 5,464,621
chronic fatigue syndrome - Aug., 5,424,300; 5,426,028
cold viruses - July, 5,422,097
coronaviruses - Jan. 96, 5,464,841
cytomegalovirus (CMV) - Mar., 5,385,839; May, 5,407,795; Sep., 5,434,074; Oct., 5,442,049; Feb. 96, 5,474,914
entomopoxvirus - Feb. 96, 5,476,781
Epstein-Barr virus (EBV) - Aug., 5,424,398
equine herpesvirus type 1 - Jan. 96, 5,470,718
equine infectious anemia virus - Aug., 5,427,907
feline immunodeficiency virus (FIV) - June, 5,413,927
feline infectious peritonitis virus - Dec., 5,460,815
feline leukemia virus - Jan. 96, 5,470,711
general (broad antiviral claims or relevance) - Feb., 5,378,451; 5,378,624; 5,378,693; 5,378,825; 5,378,841; 5,382,428; 5,382,657; 5,383,862; Mar., 5,386,023; 5,386,030; 5,387,400; 5,387,611; 5,388,592; 5,389,335; 5,389,514; 5,389,637; 5,391,546; 5,391,563; Apr., 5,391,733; 5,393,668; 5,393,878; 5,397,701; 5,399,555; May, 5,399,719; 5,399,775; 5,405,602; 5,405,939; 5,405,957; 5,407,684; 5,407,800; 5,407,949; 5,409,698; June, 5,410,045; 5,411,947; 5,413,788; 5,413,914; 5,414,000; 5,414,096; 5,416,204; 5,417,968; July, 5,417,978; 5,418,130; 5,420,020; 5,420,026; 5,420,136; 5,422,115; Aug., 5,422,123; 5,422,251; 5,422,253; 5,424,290; 5,424,308; 5,424,311; 5,424,416; 5,426,180; 5,426,183; Sep., 5,429,819; 5,430,041; 5,430,139; 5,430,155; 5,434,157; 5,434,257; 5,436,330; Oct., 5,437,287; 5,438,050; 5,439,685; 5,440,040; 5,441,734; 5,441,942; 5,441,943; 5,441,976; 5,443,829; 5,443,832; 5,443,964; 5,444,065; 5,445,953; Nov., 5,446,045; 5,446,137; 5,446,161; 5,449,664; 5,449,684; 5,449,752; 5,449,794; 5,449,840; 5,451,678; 5,451,679; 5,453,362; 5,453,496; Dec., 5,455,030; 5,455,233; 5,455,277; 5,455,339; 5,456,663; 5,457,091; 5,458,889; 5,459,030; 5,459,127; 5,459,144; 5,459,255; 5,460,956; 5,461,060; 5,462,933; Jan. 96, 5,463,122; 5,464,819; 5,464,823; 5,464,848; 5,466,450; 5,466,463; 5,466,585; 5,466,669; 5,466,702; 5,466,715; 5,466,725; 5,466,806; 5,470,570; 5,470,974; Feb. 96, 5,472,840; 5,473,074; 5,475,096; 5,476,786; 5,476,855; 5,476,938; 5,478,928
gibbon ape leukemia virus - June, 5,414,076; Jan. 96, 5,470,726
hepatitis A virus - Sep., 5,430,135; Dec., 5,459,033; Feb. 96, 5,478,746
hepatitis B virus - Feb., 5,378,605; Apr., 5,399,580; Sep., 5,432,165; 5,436,139; Oct., 5,444,063; 5,446,029; Dec., 5,462,863
hepatitis C virus - July, 5,419,906; Aug., 5,427,909; 5,428,145; Sep., 5,436,126; 5,436,318; Oct., 5,437,974; 5,443,965
hepatitis D virus - Feb., 5,378,814; Mar., 5,389,528; Oct., 5,445,932
herpes simplex virus - Feb., 5,380,754; 5,382,436; Mar., 5,385,733; Apr., 5,393,528; 5,399,583; July, 5,418,132; Aug., 5,424,315; Oct., 5,441,936; 5,441,983; Dec., 5,455,232; 5,461,075; Feb. 96, 5,476,841; 5,478,727
herpesviruses - Feb., 5,378,694; 5,380,727; 5,382,572; 5,384,122; Apr., 5,393,883; May, 5,405,850; June, 5,411,733; July, 5,422,345; Dec., 5,459,146; 5,461,029; Jan. 96, 5,463,092
HIV - Feb., 5,380,825; 5,384,134; Mar., 5,384,240; 5,385,901; 5,385,911; 5,386,022; 5,387,512; 5,387,677; 5,391,142; Apr., 5,391,746; 5,395,751; 5,399,554; May, 5,401,628; 5,401,777; 5,403,826; 5,407,794; 5,407,961; June, 5,409,810; 5,409,906; 5,409,927; 5,411,970; 5,413,999; July, 5,417,970; 5,419,899; 5,419,900; 5,420,030; 5,420,154; 5,420,264; 5,422,274; 5,424,063; Aug., 5,424,329; 5,425,944; 5,427,781; 5,428,143; 5,428,166; Sep., 5,430,064; 5,432,076; 5,432,171; 5,432,273; 5,434,188; 5,434,265; 5,436,131; 5,436,341; Oct., 5,438,118; 5,439,570; 5,439,792; 5,439,809; 5,439,892; 5,439,899; 5,441,723; 5,444,044; 5,444,085; 5,445,960; Nov., 5,447,837; 5,447,915; 5,449,685; 5,449,691; 5,449,756; 5,451,576; 5,451,671; Dec., 5,455,251; 5,456,924; 5,457,038; 5,459,056; 5,459,060; 5,459,238; 5,459,257; 5,461,154; 5,462,852; 5,462,872; 5,463,063; Jan. 96, 5,463,067; 5,463,104; 5,464,740; 5,464,748; 5,464,871; 5,464,933; 5,466,787; 5,466,793; 5,466,797; 5,468,469; 5,468,487; 5,470,720; 5,470,730; Feb. 96, 5,472,965; 5,474,894; 5,475,013; 5,475,027; 5,475,104; 5,475,136; 5,476,444; 5,476,780; 5,476,859; 5,476,874
HIV-2 - Oct., 5,443,828; Jan. 96, 5,470,702
HTLV-I/HTLV-II - Feb., 5,378,805; July, 5,420,244; Aug., 5,424,197; Dec., 5,462,853; Feb. 96, 5,476,765
human papillomavirus - Feb., 5,382,509; May, 5,401,627; June, 5,411,857; 5,415,995; Sep., 5,431,909; 5,436,127; Oct., 5,437,951; Nov., 5,447,839; Dec., 5,457,189; Jan. 96, 5,464,936
infectious bursal disease virus - Apr., 5,395,768; 5,395,769
infectious laryngotracheitis virus - Sep., 5,436,005; Oct., 5,443,831; 5,443,982
influenza viruses - Feb., 5,380,734; 5,380,832; Nov., 5,453,533; Jan. 96, 5,464,630; Feb. 96, 5,475,012; 5,475,109
Marek's Disease virus - Feb., 5,378,467
mystery swine disease virus - Feb. 96, 5,476,778
Newcastle disease virus - Aug., 5,427,791
parainfluenza virus - May, 5,401,626; Aug., 5,427,782
parvoviruses - Nov., 5,449,608
picornaviruses - Nov., 5,449,782
porcine respiratory coronavirus - July, 5,419,907
pseudorabies virus - Nov., 5,449,765; 5,451,499
respiratory syncytial virus - June, 5,412,077; July, 5,424,18
retrotransposons - Dec., 5,463,024
retroviruses - Feb., 5,378,806; Mar., 5,385,899; Apr., 5,397,794; May, 5,403,707; 5,405,776; July, 5,422,344; Aug., 5,424,426; 5,428,167; Sep., 5,430,150; 5,430,151; Nov., 5,449,614; Dec., 5,455,351; 5,457,108; 5,461,067; Jan. 96, 5,464,833; 5,464,869; Feb. 96, 5,473,063
rhinoviruses - June, 5,409,905; Nov., 5,447,840
rotaviruses - Apr., 5,395,759; Sep., 5,431,899; Feb. 96, 5,474,773
rubella virus - Aug., 5,427,792; Oct., 5,439,814
Shope fibroma virus - Jan. 96, 5,464,938
simian hepatitis A virus - Feb. 96, 5,476,658
simian immunodeficiency virus (SIV) - Jan. 96, 5,470,572
spleen necrosis virus - May, 5,403,582
swinepox virus - Feb., 5,382,425
tick-borne encephalitis virus - Mar., 5,391,491
turkey herpesvirus - Jan. 96, 5,470,734
vaccinia virus - Feb., 5,378,457; Aug., 5,426,051; Nov., 5,453,364
varicella-zoster virus - June, 5,411,738; Aug., 5,424,295; Oct., 5,446,031
Antiviral Agent Index
Substances and agents with claimed or presumed antiviral or related therapeutic activity are indexed below. Most of these are drugs and other agents which directly affect target viruses. Additional therapeutics can be found in the Vaccine and Immune Modulator Indexes below.
2',3'-didehydrodideoxynucleosides - Apr., 5,399,669; Dec., 5,455,339
2',3'-dideoxy-3'-fluoronucleosides - Aug., 5,424,416; 5,426,183; Oct., 5,446,029
2',3'-dideoxyinosine (DDI) - Apr., 5,399,554; Jan. 96, 5,466,793
2',3'-dideoxynucleosides - Nov., 5,451,671
3'-azido-3'-deoxythymidine (AZT) - Feb., 5,380,825; Mar., 5,387,677; Jan. 96, 5,464,748; 5,466,787
acemannan - Oct., 5,441,943
adeno-associated virus vectors - Feb. 96, 5,474,935
Amaryllidaceae lectins - Dec., 5,462,853
amine macrocyclics - Dec., 5,457,194
amino acid deriv. - Sep., 5,430,041; Nov., 5,446,161; 5,451,678
antisense oligonucleotides - Feb., 5,378,825; Mar., 5,386,020; 5,386,023; 5,389,514; Apr., 5,391,723; 5,395,928; 5,399,676; May, 5,405,939; 5,407,801; July, 5,417,978; 5,422,251; Aug., 5,422,253; 5,426,180; Sep., 5,432,272; 5,434,257; Oct., 5,442,049; Nov., 5,446,137; 5,453,496; Dec., 5,455,233; 5,457,189; 5,459,255; Jan. 96, 5,470,974; Feb. 96, 5,475,096
avipoxvirus vectors - Mar., 5,387,519; May, 5,403,582
azaquinoxalines - Aug., 5,424,311
azido-fatty acid analogs - Apr., 5,397,701
azo dyes - Jan. 96, 5,468,469
azoic compounds - Apr., 5,399,555
benzenemethanamines - May, 5,407,961
benzopyran phenols - Nov., 5,449,794
benzothiophenes - Aug., 5,424,315
Bifidobacterium thermophilum - Feb. 96, 5,478,559
bile acid deriv. - Dec., 5,462,933
BU-4224V - Jan. 96, 5,466,450
butanes, diaminedihydroxy- - Sep., 5,430,155
butylated hydroxytoluene - Mar., 5,385,733
C-8.2 phospholipid - Jan. 96, 5,464,740
caffeine - Feb., 5,382,436
calixnarene - Oct., 5,441,983
camptothecin - Aug., 5,428,166
carbocyclic nucleosides - Dec., 5,461,152
carbostyril deriv. - Jan. 96, 5,464,833
castanospermine esters - Mar., 5,385,911
cationic lipids - Dec., 5,459,127
CD4 - July, 5,420,264; 5,422,274
CD4 antibodies - July, 5,424,066
CD4+/CD8+ cells - May, 5,407,794
CD4-Pseudomonas exotoxin - Aug., 5,428,143
chlorine dioxide - Feb., 5,384,134
cholic acid - Oct., 5,439,685
chordopoxvirus - Oct., 5,445,953
chorionic gonadotropin - Feb., 5,382,428
cold sterilants - May, 5,405,602; 5,407,949
controlled release polymers - Aug., 5,422,123
cosalanes - Oct., 5,439,899
COVAM therapy - July, 5,422,097
CR1 antibody-RBC complexes - Jan. 96, 5,470,570
curcumin - May, 5,401,777
cyanoamidine deriv. - Feb. 96, 5,475,012
cyanoamine deriv. - Feb., 5,380,734
cyclic imides - Dec., 5,463,063
cyclic ureas - Jan. 96, 5,466,797
cyclocytidine - May, 5,399,682
cyclopropane purine/pyrimidines - Nov., 5,449,840
cystine deriv. - Oct., 5,441,976
cytomegalovirus proteinase - Sep., 5,434,074
dehydroepiandrosterone (DHEA) - May, 5,407,684
deoxynojirimycins - Apr., 5,391,746; Sep., 5,436,341
dextrin sulfate - Oct., 5,439,892
dideoxy-beta-nucleosides - June, 5,416,204
dideoxy-imino-D-glucitol deriv. - Feb. 96, 5,476,859
dideoxyinosine, 2',3'- (DDI) - Apr., 5,399,554; Jan. 96, 5,466,793
dideoxynucleosides, 3'-substituted-2',3'- - Sep., 5,432,273
difluoronucleosides - Sep., 5,434,254
difluoronucleotides, 2'-deoxy-2',2'- - May, 5,401,838
dihydrodibenzazepine-6,11-dione-11-oximes - Mar., 5,385,899
dimercaptan acids - Jan. 96, 5,464,869
dioxobutanoic acid deriv. - Feb. 96, 5,475,109
disinfectant microcapsules - Feb., 5,383,862
DP-178 peptides - Jan. 96, 5,464,933
enhancins - Feb. 96, 5,475,090
filters - Mar., 5,390,668
fluorinated compounds - Dec., 5,458,889
ganglioside GM3 analogs - Feb., 5,380,832
gene therapy - Feb., 5,378,806; Apr., 5,399,346; 5,399,493; May, 5,405,779; June, 5,413,923; Jan. 96, 5,470,726
glucitol,1,5-dideoxy-1,5-imino-D- deriv. - June, 5,411,970
grapefruit extracts - Aug., 5,425,944
guanine nucleosides - Nov., 5,446,045
guanosines, dideoxy-didehydro- - Oct., 5,441,942
halodideoxy-1,5-imino-D-glucitols - Nov., 5,451,679
halogenopurine deriv. - Mar., 5,389,637
halogenopurine, 2-amino-6- - Apr., 5,391,733; Oct., 5,440,037
halomethylidene nucleosides - Feb., 5,378,693
heparin-binding protein - Dec., 5,461,029
hepatitis C virus peptides - Sep., 5,436,126
HIV monoclonal antibodies - Oct., 5,445,960; Dec., 5,459,060
HIV peptides - Dec., 5,459,238
HIV protease - Sep., 5,436,131
HIV protease inhibitors - June, 5,413,999; Aug., 5,424,426; Sep., 5,434,265; Oct., 5,438,118; Dec., 5,461,154; Jan. 96, 5,463,067; Feb. 96, 5,475,136
HIV-1 polypeptides - Oct., 5,444,044
host cell factor (HCF) - Nov., 5,453,362
HTLV-I/HTLV-II peptides - Feb., 5,378,805; Feb. 96, 5,476,765
hydroxyapatite - Oct., 5,443,832
hyperthermia - Mar., 5,391,142;ÊFeb. 96, 5,476,444
imidazo(4,5-c)-quinolin-4-amines - Mar., 5,389,640
imidazoles - Feb. 96, 5,472,965
imidazopyridin-4-amines - Oct., 5,444,065
immune adsorption filters - Feb., 5,378,624
immune globulin - July, 5,419,906
immunoglobulin, RSV - June, 5,412,077
indole-2-carboxamides - Aug., 5,424,329
indolocarbazoles - Oct., 5,438,050
interferon, alpha - Feb., 5,378,457; Dec., 5,460,956
interferon, alpha-2, zinc - Oct., 5,441,734
interferon, beta - Jan. 96, 5,468,607; 5,468,608; 5,468,609
interferon, fibroblast - Dec., 5,460,811
interferon, PEG- - Feb., 5,382,657
interferon-induced proteins - Jan. 96, 5,466,585
interferons - Feb., 5,378,823; Sep., 5,431,909
interleukin-1 receptor - Jan. 96, 5,470,730
interleukin-2 liposomes - May, 5,409,698
interleukin-2 - Apr., 5,399,669; July, 5,417,970; 5,419,899; 5,419,900; Nov., 5,449,691; 5,449,756
iodine solutions - Oct., 5,437,287
iodouracil,1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5- (FIAU) - Sep., 5,432,165
L-particles - Feb., 5,384,122
lactoferrin peptides - Jan. 96, 5,466,669
lidocaine - June, 5,411,738
lipid prodrugs - June, 5,411,947
liposomes - Apr., 5,399,669; Jan. 96, 5,464,630
lithium salt fatty acids - July, 5,422,115
macrocyclic compounds - Dec., 5,457,111
mafenide - Feb., 5,378,451
marine sponge deriv. - Nov., 5,449,684
methionine - Sep., 5,430,064
methoxypsoralen - Dec., 5,459,030
michellamines - Dec., 5,455,251
microwave heating - Mar., 5,389,335
morpholin-4-ylamides - June, 5,409,927
Na+/nucleoside cotransporter proteins - June, 5,410,031
nanocrystal vaccine carriers - Dec., 5,462,750
naphthalene-2-carboxamide ethers - Sep., 5,434,188
naphthalimides - July, 5,420,136
natural killer cells - June, 5,415,874
natural killer stimulatory factor - Dec., 5,457,038
neuraminidase inhibitors - Nov., 5,453,533
nitrohalo/nitroso compounds - Jan. 96, 5,464,871
nitropyrrole nucleosides - Oct., 5,438,131
nitroso-1,2-aromatics - Feb. 96, 5,473,074
nonoxynol oligomers - Feb., 5,380,523
nonoxynol-9 - Apr., 5,393,528; June, 5,417,968
nucleosides - Apr., 5,393,879; 5,399,580; July, 5,420,266; Nov., 5,449,664
nucleosides, 2'-alkylidenepyrimidine - Sep., 5,430,139
nucleosides, alpha- - June, 5,409,906
nucleosides, bicyclic - Apr., 5,393,878
nucleosides, cyclobutane - May, 5,399,775
nucleosides, deoxydifluoro-4-pyrimidine - Sep., 5,430,026
nucleosides, dioxolanyl purine - Oct., 5,444,063
nucleotides - Feb. 96, 5,476,938
oligomers - July, 5,424,063
oligonucleotide deriv. - Apr., 5,391,785
oligopeptide sulfonamides - Feb. 96, 5,476,874
opioid receptor antagonists - Jan. 96, 5,464,841
organo-silicon compounds - Mar., 5,391,546
oxadiazolyl-phenoxyalkylisoxazoles - Jan. 96, 5,464,848
oxathiolanes - Jan. 96, 5,466,806
oxazolinyl deriv. - Nov., 5,449,782
oxo-dibenzo-cycloheptadienes - Dec., 5,457,108
ozone - Mar., 5,387,400
PAF inhibitors - Dec., 5,459,144
parabactin - Mar., 5,391,563
peptide deriv. - Aug., 5,424,290; Oct., 5,439,792; 5,441,936; Nov., 5,447,915; Jan. 96, 5,464,819; 5,464,823; Feb. 96, 5,476,841
phenols, 3,4-disubstituted - Jan. 96, 5,466,715
phenylthiols - Jan. 96, 5,463,122
phosphonoacid deriv. - Jan. 96, 5,463,092
phosphonomethoxy methoxy purines/pyrimidines - Mar., 5,386,030
photoinactivation - July, 5,418,130; Dec., 5,459,030; Feb. 96, 5,476,841
piperazines - Dec., 5,455,351
plant glycolipids - Feb., 5,382,430
plant drugs - June, 5,411,733
polyhydric alcohols - Oct., 5,441,723
polypeptides - Nov., 5,449,752
polysaccharides - Aug., 5,424,300
porphacyanines - May, 5,405,957
porphyrins, green - Apr., 5,399,583
poxvirus vectors - Oct., 5,443,964
protease inhibitors - June, 5,413,914
protein-tyrosine kinase - Sep., 5,432,076
pseudopeptides, trifluoromethyl - Sep., 5,430,151
pseudovirus particles - Oct., 5,443,969
psoralen-DNA monoadducts - May, 5,399,719; Dec., 5,462,733
purine nucleosides - Nov., 5,446,139
purine, arabinofuranosyl-2-amino-6-methoxy - Aug., 5,424,295
pyrazole 3-oxo-propanenitrile - Aug., 5,424,308
pyrazoloquinoline deriv. - Dec., 5,459,146
pyridinone deriv. - Mar., 5,387,512
pyrimidine deriv. - Dec., 5,461,060
pyrimidine nucleosides - Oct., 5,440,040
pyrimidines, triazolo- - Dec., 5,457,091
pyrimidinols, 6-aryl - - Sep., 5,434,157
pyrrolidinones - July, 5,420,154
quaternary ammonium compounds - Aug., 5,424,323
quinoline deriv. - Feb., 5,378,694; 5,382,572
retinoids - Dec., 5,456,663
retroviral protease inhibitors - Aug., 5,428,167; Sep., 5,430,150; Dec., 5,461,067
reverse transcriptase - May, 5,405,776
rhamnolipids - Dec., 5,455,232
ribonucleosides, alpha-morpholino - Feb., 5,378,841
ribonucleotide reductase inhibitors - Feb., 5,380,727
ribozymes - Sep., 5,436,330; Feb. 96, 5,472,840
Ricinus extracts - Jan. 96, 5,468,487
rubyrin - June, 5,410,045
SAF lymphokine - Aug., 5,427,781
saponins - Oct., 5,443,829
silver compounds - June, 5,413,788
single chain antibodies - Dec., 5,455,030; Feb. 96, 5,476,786
spermicides - Mar., 5,387,611
spermines - Dec., 5,455,277
succinoylaminohydroxyethyl sulfonamides - Jan. 96, 5,463,104
sulfated oligoglycoside acylates - Dec., 5,459,257
surfactants - Feb., 5,380,754; Dec., 5,459,033
surfactants, nonionic - Jan. 96, 5,466,725
swainsonine - Jan. 96, 5,466,809
T-cell 5c8 antibody - Feb. 96, 5,474,771
tetrahydrofuran nucleosides - Feb. 96, 5,473,063
tetrahydropyrans - June, 5,414,000; 5,414,096
texaphyrins - Sep., 5,432,171; Oct., 5,439,570; Nov., 5,451,576; Feb. 96, 5,475,104
thiazoloisoindolinones - Apr., 5,397,794
thiocarbonohydrazone, 2-acetylpyridine-5- - May, 5,405,850
thiocarbonohydrazones - Apr., 5,393,883
thioribonucleosides, 2',3'-dideoxy-4'- - Feb. 96, 5,478,928
thiosulfates salts - Sep., 5,429,819
thymidine phosphotriesters - Apr., 5,393,744
topoisomerase I inhibitors - July, 5,422,344
tumor necrosis factor antagonists - Mar., 5,385,901
universal donor cells - June, 5,416,260
uracil, arabinofuranosyl-halogenovinyl - July, 5,422,345; Oct., 5,446,031
urea hydroxyethylamine peptides - Feb. 96, 5,475,013; 5,475,027
vaccinia virus - Aug., 5,426,051; Nov., 5,453,364
vaginal pessary - Jan. 96, 5,466,463
vanilloid compounds - Dec., 5,461,075
vibriobactin - Jan. 96, 5,466,702
whey protein - Dec., 5,456,924
zinc compounds - June, 5,409,905
Vaccine Index
Viral vaccines and vectors are indexed below.
adeno-associated virus - Sep., 5,436,146; Feb. 96, 5,474,935
avipoxvirus vectors - Mar., 5,387,519
bovine herpesvirus 1 - Dec., 5,462,734
bovine immunodeficiency-like virus - Feb., 5,380,830
canine coronavirus vaccine - Jan. 96, 5,464,621
chordopoxvirus - Oct., 5,445,953
cytomegalovirus - Mar., 5,385,839; Feb. 96, 5,474,914
entomopoxvirus - Feb. 96, 5,476,781
Epstein-Barr virus - Aug., 5,424,398
equine herpesvirus type 1 - Jan. 96, 5,470,718
equine infectious anemia virus - Aug., 5,427,907
feline immunodeficiency virus - June, 5,413,927
feline infectious peritonitis virus - Dec., 5,460,815
general - Feb., 5,378,457; Apr., 5,393,668; July, 5,420,020; July, 5,420,026; Oct., 5,443,829; 5,443,832; 5,443,964; 5,445,953; Dec., 5,455,030; 5,463,024; Jan. 96, 5,464,630; 5,470,570; Feb. 96, 5,476,786
gibbon ape leukemia virus - June, 5,414,076
hepatitis A virus - Sep., 5,430,135; Feb. 96, 5,476,658; 5,478,746
hepatitis B virus - Sep., 5,436,139; Dec., 5,462,863
hepatitis D virus - Feb., 5,378,814; Mar., 5,389,528; Oct., 5,445,932
herpesviruses - Feb., 5,384,122
HIV - Mar., 5,387,512; July, 5,420,030; Oct., 5,439,809; 5,445,960; Dec., 5,459,238
HIV-2 - Oct., 5,443,828; Jan. 96, 5,470,702
HTLV-I/HTLV-II - Feb., 5,378,805;ÊApr., 5,397,696
human papillomavirus - May, 5,401,627; Oct., 5,437,951
infectious bursal disease virus - Apr., 5,395,768; 5,395,769
infectious laryngotracheitis virus - Sep., 5,436,005; Oct., 5,443,831; 5,443,982
influenza virus - Jan. 96, 5,464,630
Marek's Disease virus - Feb., 5,378,467
mystery swine disease virus - Feb. 96, 5,476,778
Newcastle disease virus - Aug., 5,427,791
parainfluenza virus - May, 5,401,626; Aug., 5,427,782
porcine respiratory coronavirus - July, 5,419,907
pseudorabies virus - Nov., 5,449,765; 5,451,499
respiratory syncytial virus - June, 5,412,077
retrotransposons - Dec., 5,463,024
retroviruses - Feb., 5,378,806; Apr., 5,395,759;Feb. 96, 5,474,773
rubella virus - Aug., 5,427,792; Oct., 5,439,814
simian hepatitis A virus - Feb. 96, 5,476,658
SIV - Jan. 96, 5,470,572
spleen necrosis virus - May, 5,403,582
swinepox virus - Feb., 5,382,425
tick-borne encephalitis virus - Mar., 5,391,491
turkey herpesvirus - Feb., 5,378,467; Jan. 96, 5,470,734
vaccinia viruses - Feb., 5,378,457; Aug., 5,426,051; Nov., 5,453,364
Immune Modulator Index
Immune stimulants, modulators and vaccine adjuvants are indexed below.
Actinomyces pyogenes - Feb. 96, 5,478,559
amine macrocyclics - Dec., 5,457,194
benzopyran phenols - Nov., 5,449,794
Bifidobacterium thermophilum - Feb. 96, 5,478,559
CD4 antibodies - July, 5,424,066
chorionic gonadotropin - Feb., 5,382,428
cyclic imides - Dec., 5,463,063
cystine deriv. - Oct., 5,441,976
dehydroepiandrosterone (DHEA) - May, 5,407,684
enteral nutrition - May, 5,403,826
gene therapy - June, 5,413,923
guanosines, dideoxy-didehydro- - Oct., 5,441,942
hydroxyapatite - Oct., 5,443,832
imidazo(4,5-c)-quinolin-4-amines - Mar., 5,389,640
imidazopyridin-4-amines - Oct., 5,444,065
immune globulin - July, 5,419,906
interferon, alpha-2 - Dec., 5,460,956
interferon, alpha-2, zinc - Oct., 5,441,734
interferon, beta - Jan. 96, 5,468,607; 5,468,608; 5,468,609
interferon, fibroblast - Dec., 5,460,811
interferon, PEG- - Feb., 5,382,657
interferon-induced proteins - Jan. 96, 5,466,585
interferons - Feb., 5,378,823; Sep., 5,431,909
interleukin-1 receptor - Jan. 96, 5,470,730
interleukin-2 - Apr., 5,399,669; May, 5,409,698; July, 5,417,970; 5,419,899; 5,419,900; Nov., 5,449,691; 5,449,756
interleukin-12 - Dec., 5,457,038
lactoferrin peptides - Jan. 96, 5,466,669
macrocyclic compounds - Dec., 5,457,111
natural killer cells - June, 5,415,874
natural killer stimulatory factor - Dec., 5,457,038
opioid receptor antagonists - Jan. 96, 5,464,841
peptides - Jan. 96, 5,464,819
phenols, 3,4-disubstituted - Jan. 96, 5,466,715
plant glycolipids - Feb., 5,382,430
protein-tyrosine kinase - Sep., 5,432,076
psoralen-DNA monoadducts - Dec., 5,462,733
pyrimidinols, 6-aryl - - Sep., 5,434,157
pyrrolidinones - July, 5,420,154
SAF lymphokine - Aug., 5,427,781
saponins - Oct., 5,443,829
swainsonine - Jan. 96, 5,466,809
T-cell 5c8 antibody - Feb. 96, 5,474,771
T-cell culture - Feb. 96, 5,476,780
thalidomide - Dec., 5,463,063
tumor necrosis antagonists - Mar., 5,385,901; Jan. 96, 5,464,938
universal donor cells - June, 5,416,260
Diagnostics Index
Diagnostics and assays are indexed by viral target or disease.
chronic fatigue syndrome - Aug., 5,426,028
cytomegalovirus - May, 5,407,795
entomopoxvirus - Feb. 96, 5,476,781
feline leukemia virus - Jan. 96, 5,470,711
general - Feb., 5,378,841; May, 5,407,800
hepatitis A virus - Dec., 5,459,033
hepatitis B virus - Feb., 5,378,605; Sep., 5,436,139; Dec., 5,462,863
hepatitis C virus - Aug., 5,427,909; 5,428,145; Sep., 5,436,126; 5,436,318; Oct., 5,437,974; 5,443,965
hepatitis D virus - Feb., 5,378,814; Mar., 5,389,528; Oct., 5,445,932
herpes simplex virus - July, 5,418,132
HIV - Mar., 5,384,240; Apr., 5,395,751; May, 5,401,628; 5,407,794; June, 5,409,810; Sep., 5,436,131; Oct., 5,439,792; Nov., 5,447,837; Dec., 5,459,060; 5,462,852; Jan. 96, 5,464,740; 5,470,720; Feb. 96, 5,474,894
HIV-2 - Oct., 5,439,792; 5,443,828; Jan. 96, 5,470,702
HTLV-I - Feb., 5,378,805; July, 5,420,244; Oct., 5,439,792; Feb. 96, 5,476,765
human papillomavirus - Feb., 5,382,509; May, 5,401,627; June, 5,411,857; 5,415,995; Sep., 5,436,127; Oct., 5,437,951; Nov., 5,447,839
mystery swine disease virus - Feb. 96, 5,476,778
parvovirus - Nov., 5,449,608
respiratory syncytial virus - July, 5,424,189
retroviruses - May, 5,403,707
rhinoviruses - Nov., 5,447,840
rotavirus - Sep., 5,431,899
rubella virus - Aug., 5,427,792
SIV - Jan. 96, 5,470,572
Recombinant DNA/RNA Index
Patents involving recombinant DNA/RNA technologies are indexed below by virus. Entries often refer to recombinant antigens and, sometimes, viral vectors.
adeno-associated virus - Sep., 5,436,146; Feb. 96, 5,474,935
avipoxvirus vectors - Mar., 5,387,519
bovine immunodeficiency-like virus - Feb., 5,380,830
chordopoxvirus - Oct., 5,445,953
cytomegalovirus - Mar., 5,385,839; May, 5,407,795; Sep., 5,434,074; Oct., 5,442,049; Feb. 96, 5,474,914
Epstein-Barr virus- Aug., 5,424,398
feline immunodeficiency virus - June, 5,413,927
general - Feb., 5,382,657; Mar., 5,389,514; May, 5,407,800; 5,409,698; July, 5,417,978; 5,420,020; 5,420,026; Sep., 5,436,330; Oct., 5,441,734; 5,443,964; 5,445,953; Dec., 5,455,030; 5,460,956; 5,463,024; Feb. 96, 5,476,786
gibbon ape leukemia virus - June, 5,414,076; Jan. 96, 5,470,726
hepatitis A virus (HAV) - Sep., 5,430,135; Feb. 96, 5,478,746
hepatitis B virus - Sep., 5,436,139; Dec., 5,462,863
hepatitis C virus - Aug., 5,428,145; Oct., 5,437,974; 5,443,965
hepatitis D virus - Feb., 5,378,814; Mar., 5,389,528
herpes simplex virus - Feb. 96, 5,478,727
herpesviruses - Feb., 5,384,122; Dec., 5,461,029
HIV - Mar., 5,386,022; July, 5,417,970; 5,419,899; 5,419,900; 5,420,030; 5,420,264; 5,422,274; Aug., 5,428,143; Sep., 5,432,076; Oct., 5,439,809; Nov., 5,449,691; 5,449,756; Dec., 5,457,038; Jan. 96, 5,470,730
HIV-2 - Oct., 5,443,828; Jan. 96, 5,470,702
HTLV-I/HTLV-II - Aug., 5,424,197
human papillomavirus - May, 5,401,627; Sep., 5,431,909; Oct., 5,437,951
infectious bursal disease virus - Apr., 5,395,769
infectious laryngotracheitis virus - Oct., 5,443,831
parainfluenza virus - May, 5,401,626; Aug., 5,427,782
pseudorabies virus - Nov., 5,449,765; 5,451,499
retrotransposons - Dec., 5,463,024
retroviruses - Feb., 5,378,806; May, 5,405,776; Nov., 5,449,614
rotaviruses - Apr., 5,395,759
rubella virus - Aug., 5,427,792; Oct., 5,439,814
spleen necrosis virus - May, 5,403,582
swinepox virus - Feb., 5,382,425
turkey herpesvirus - Jan. 96, 5,470,734
vaccinia virus - Aug., 5,426,051
Nucleoside/Nucleotide Patents
Patents involving nucleosides, nucleotides, antisense agents and other related technologies are listed below.
Feb., 5,378,605; 5,378,693; 5,378,825; 5,378,841; 5,380,727; 5,380,825; 5,382,509; Mar., 5,386,020; 5,386,022; 5,386,023; Apr., 5,391,723; 5,391,785; 5,393,744; 5,393,878; 5,393,879; 5,395,928; 5,399,554; 5,399,580; 5,399,676; May, 5,399,682; 5,399,775; 5,401,838; 5,403,707; 5,405,850; 5,405,939; 5,407,795; 5,407,801; June, 5,409,906; 5,410,031; 5,410,033; 5,411,857; 5,411,947; July, 5,417,978; 5,420,266; 5,422,251; Aug., 5,422,253; 5,424,416; 5,426,180; 5,426,183; 5,427,909; Sep., 5,430,026; 5,432,272; 5,432,273; 5,434,257; Oct., 5,438,131; 5,440,037; 5,440,040; 5,442,049; 5,444,063; 5,446,029; 5,446,031; Nov., 5,446,045; 5,446,137; 5,446,139; 5,447,839; 5,449,664; 5,453,496; Dec., 5,457,189; 5,461,152; Jan. 96, 5,470,974; Feb. 96, 5,472,840; 5,473,063; 5,475,096; 5,476,930; 5,476,938; 5,478,928
Blood Treatment Patents
Patents involving antiviral treatments or processing of blood or blood products are listed below.
Mar., 5,391,142; May, 5,399,719; June, 5,412,077; July, 5,419,906; Oct., 5,439,570; Nov., 5,451,576; Dec., 5,459,030; Feb. 96, 5,475,104; 5,476,444
Disinfectant/Sterilization Patents
Patents involving disinfection, sterilization and related technologies are listed below.
Feb., 5,378,624; 5,383,862; Mar., 5,389,335; Apr., 5,399,555; May, 5,399,719; 5,405,602; 5,405,957; June, 5,417,968; July, 5,418,130; 5,419,906; 5,420,136; Aug., 5,424,323; Sep., 5,429,819; 5,432,171; Oct., 5,437,287; Jan. 96, 5,466,725
Veterinary Use Patents
Patents involving veterinary applications are listed below.
Feb., 5,380,830; 5,382,425; Apr., 5,395,768; May, 5,403,582; June, 5,413,927; 5,414,076; July, 5,424,189; Sep., 5,436,005; Oct., 5,443,831; 5,443,982; Nov., 5,449,765; Dec., 5,462,734; Jan. 96, 5,464,621; 5,470,711; 5,470,718; 5,470,734; Feb. 96, 5,476,778; 5,476,781